Infectious posterior uveitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:279919H32.0
Who is this for?
Show terms as
18Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Infectious posterior uveitis is an inflammatory condition affecting the posterior segment of the eye — specifically the choroid and retina — caused by an identifiable infectious agent. Unlike non-infectious (autoimmune) forms of uveitis, this condition results from direct invasion or immune response to pathogens including Toxoplasma gondii (the most common cause worldwide), cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV), Mycobacterium tuberculosis, Treponema pallidum (syphilis), and various fungi. The condition may present as focal or multifocal chorioretinitis, retinitis, retinochoroiditis, or neuroretinitis depending on the causative organism. Patients typically experience blurred vision, floaters, photophobia, and in some cases significant visual loss. The inflammation can lead to complications such as vitreous opacities, retinal detachment, macular edema, optic nerve involvement, and permanent visual impairment if not promptly treated. Immunocompromised individuals — including those with HIV/AIDS, organ transplant recipients, or patients on immunosuppressive therapy — are at particularly high risk for severe or atypical presentations. Treatment is directed at the underlying infectious cause and typically involves targeted antimicrobial therapy. For toxoplasmic retinochoroiditis, combinations of pyrimethamine, sulfadiazine, and corticosteroids are commonly used. Viral causes are treated with antiviral agents such as ganciclovir, valganciclovir, or acyclovir. Antitubercular therapy or antibiotics are employed for bacterial etiologies. Adjunctive corticosteroids may be used cautiously to control inflammation, but only in conjunction with appropriate antimicrobial coverage to avoid worsening the infection. Early diagnosis through clinical examination, serologic testing, aqueous or vitreous sampling with PCR, and imaging is essential for optimal outcomes.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Aug 2024Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

Alimera Sciences — PHASE4

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Infectious posterior uveitis.

View clinical trials →

No actively recruiting trials found for Infectious posterior uveitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Infectious posterior uveitis community →

Specialists

18 foundView all specialists →
LP
Laurence Bouillet, Professor
Grenoble
Specialist

Rare Disease Specialist

PI on 3 active trials
AM
Alessandro Invernizzi, MD
Specialist
PI on 1 active trial1 Infectious posterior uveitis publication
TM
Thomas Ciulla, MD
CARMEL, IN
Specialist
PI on 8 active trials
QM
Quan D Nguyen, MD MSc
Specialist
PI on 2 active trials
QM
Quan D Nguyen, MD, MSc
Specialist
PI on 5 active trials
TM
Thomas Cuilla, MD, MBA
Specialist
PI on 1 active trial
AP
Andy Payne
Specialist
PI on 1 active trial17 Infectious posterior uveitis publications
TC
Thomas A Crescuillo
Specialist
PI on 1 active trial12 Infectious posterior uveitis publications
BP
Brendan Johnson, PhD
Specialist
PI on 1 active trial
JM
Janet T Holbrook, PhD, MPH
Specialist
PI on 1 active trial
MM
Michael Altaweel, MD
MADISON, WI
Specialist
PI on 2 active trials
CM
Carlos Pavesio, MD
Specialist
PI on 1 active trial
LM
Lanita Scott, MD
INGLEWOOD, CA
Specialist
PI on 1 active trial1 Infectious posterior uveitis publication
GM
Glenn Jaffe, MD
DURHAM, NC
Specialist
PI on 1 active trial
AM
Antoine AB BREZIN, MD
Specialist
PI on 1 active trial1 Infectious posterior uveitis publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Infectious posterior uveitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Infectious posterior uveitisForum →

No community posts yet. Be the first to share your experience with Infectious posterior uveitis.

Start the conversation →

Latest news about Infectious posterior uveitis

Disease timeline:

New recruiting trial: Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

A new clinical trial is recruiting patients for Infectious posterior uveitis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Infectious posterior uveitis

What is Infectious posterior uveitis?

Infectious posterior uveitis is an inflammatory condition affecting the posterior segment of the eye — specifically the choroid and retina — caused by an identifiable infectious agent. Unlike non-infectious (autoimmune) forms of uveitis, this condition results from direct invasion or immune response to pathogens including Toxoplasma gondii (the most common cause worldwide), cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV), Mycobacterium tuberculosis, Treponema pallidum (syphilis), and various fungi. The condition may present as focal or multifocal chorioretinitis

Which specialists treat Infectious posterior uveitis?

18 specialists and care centers treating Infectious posterior uveitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.